ROCKVILLE, Md. (August 2, 2019) — The following statement may be attributed to LaVarne A. Burton, president and chief executive officer of the American Kidney Fund (AKF).
"The American Kidney Fund is pleased to hear today that the U.S. Department of Justice, after a lengthy investigation that began in 2016 and with which we cooperated fully, has declined to intervene in the case. We now know that this suit was brought by a former employee who, prior to making this complaint, was terminated for cause.
"AKF strictly adheres to the federal advisory opinion that governs our charitable premium assistance program, and we have in place strict safeguards and conflict of interest policies to ensure that. Our program provides a vital safety net for low-income dialysis and transplant patients for whom access to health care is a matter of life and death."
About the American Kidney Fund
The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 20 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.